UNICA IRIS Institutional Research Information System

TRAMONTANO, ENZO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 399.485
NA - Nord America 12.575
AS - Asia 2.098
AF - Africa 35
SA - Sud America 18
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 13
Totale 414.238
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 396.304
US - Stati Uniti d'America 12.502
CN - Cina 1.239
SE - Svezia 986
UA - Ucraina 943
SG - Singapore 416
DE - Germania 414
FI - Finlandia 300
GB - Regno Unito 277
VN - Vietnam 176
FR - Francia 75
CA - Canada 64
IN - India 61
HK - Hong Kong 49
KR - Corea 48
TR - Turchia 29
NL - Olanda 26
BE - Belgio 23
IR - Iran 23
PL - Polonia 17
AT - Austria 16
CZ - Repubblica Ceca 14
ES - Italia 14
RU - Federazione Russa 14
AU - Australia 12
EU - Europa 11
PK - Pakistan 11
IE - Irlanda 10
IL - Israele 10
DK - Danimarca 8
JP - Giappone 8
PT - Portogallo 8
MA - Marocco 7
MX - Messico 7
BR - Brasile 6
CH - Svizzera 6
CL - Cile 6
IQ - Iraq 6
ZA - Sudafrica 6
DZ - Algeria 5
GR - Grecia 5
LV - Lettonia 5
NO - Norvegia 5
HU - Ungheria 4
MU - Mauritius 4
NG - Nigeria 4
TN - Tunisia 4
TW - Taiwan 4
AR - Argentina 3
HR - Croazia 3
ID - Indonesia 3
OM - Oman 3
RO - Romania 3
TH - Thailandia 3
A1 - Anonimo 2
BD - Bangladesh 2
EG - Egitto 2
LU - Lussemburgo 2
NZ - Nuova Zelanda 2
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
BG - Bulgaria 1
CI - Costa d'Avorio 1
CO - Colombia 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
EE - Estonia 1
GE - Georgia 1
GH - Ghana 1
KG - Kirghizistan 1
MY - Malesia 1
PE - Perù 1
PH - Filippine 1
SA - Arabia Saudita 1
SD - Sudan 1
SI - Slovenia 1
Totale 414.238
Salva come PNG Salva come JPEG
Città #
Cagliari 385.344
Uta 9.827
Fairfield 1.590
Woodbridge 1.319
Chandler 993
Ashburn 917
Houston 805
Boardman 743
Nyköping 726
Seattle 643
Wilmington 640
Ann Arbor 561
Cambridge 549
Jacksonville 469
Dearborn 349
New York 250
Singapore 225
Shanghai 210
Santa Clara 207
Nanjing 181
Dong Ket 170
Boston 162
Helsinki 157
Beijing 142
San Diego 99
Redwood City 88
Milan 87
Herndon 71
Los Angeles 67
Nanchang 64
Guangzhou 58
Rome 57
Mountain View 53
Shenyang 50
Changsha 43
Seoul 41
Jiaxing 40
Sassari 40
Hebei 38
Toronto 37
Washington 35
Hong Kong 34
Redmond 33
London 32
Phoenix 32
Munich 28
Norwalk 28
Tianjin 27
Verona 27
Atlanta 26
Jinan 25
Wuhan 25
Brussels 21
Falls Church 20
Ottawa 20
Siracusa 20
Zhengzhou 20
Bultei 18
Pune 17
Hefei 16
Orange 16
Hangzhou 15
Vienna 15
Amsterdam 14
Kunming 14
Ningbo 14
Istanbul 12
Warsaw 12
Auburn Hills 11
Quartu Sant'elena 11
Wuxi 11
Brno 10
Cosenza 10
Frankfurt am Main 10
Jinhua 10
Napoli 10
Salerno 10
Borås 9
Dublin 9
Millbury 9
Naples 9
Tappahannock 9
Chicago 8
Indiana 8
Kilburn 8
Mumbai 8
Taizhou 8
Capoterra 7
Liverpool 7
Perugia 7
Sestu 7
Bhubaneswar 6
Carbonia 6
Chengdu 6
Covilha 6
Florence 6
Gujranwala 6
Menlo Park 6
Padova 6
Rabat 6
Totale 408.988
Salva come PNG Salva come JPEG
Nome #
Comparing the responses of countries and National Health Systems to the COVID-19 pandemic: a critical analysis with a case-report series 20.524
(3Z)-3-(2-[4-(aryl)-1,3-thiazol-2-yl]hydrazin-1-ylidene)-2,3-dihydro- 1H -indol-2-one derivatives as dual inhibitors of HIV-1 reverse transcriptase 14.586
Natural product-inspired esters and amides of ferulic and caffeic acid as dual inhibitors of HIV-1 reverse transcriptase 4.544
Design, synthesis, and biological evaluation of 1,3-diarylpropenones as dual inhibitors of HIV-1 reverse transcriptase 4.349
Biological activities of aerial parts extracts of Euphorbia characias 4.299
Quercetin blocks Ebola Virus infection by counteracting the VP24 Interferon inhibitory function 4.256
Ribonuclease H/DNA polymerase HIV-1 reverse transcriptase dual inhibitor: mechanistic studies on the allosteric mode of action of isatin-based compound RMNC6 4.201
Isatin thiazoline hybrids as dual inhibitors of HIV-1 reverse transcriptase 4.044
Identification of Myricetin as Ebolavirus VP35-dsRNA interaction inhibitor through a novel fluorescence-based assay 3.566
Design, synthesis and antiviral evaluation of novel heteroarylcarbothioamide derivatives as dual inhibitors of HIV-1 Reverse transcriptase-associated RNase H and RDDP functions 3.360
Identification of HIV-1 reverse transcriptase dual inhibitors by a combined shape-, 2D-fingerprint- and pharmacophore-based virtual screening approach 3.333
Uvaria angolensis as a promising source of inhibitors of HIV-1 RT-associated RNA-dependent DNA polymerase and RNase H functions 3.316
Sennoside A, derived from the traditional chinese medicine plant Rheum L., is a new dual HIV-1 inhibitor effective on HIV-1 replication 3.309
Onopordum illyricum L.: new anti HIV-1 agents from a Mediterranean edible plant 3.293
Dual HIV-1 reverse transcriptase and integrase inhibitors from Limonium morisianum Arrigoni, an endemic species of Sardinia (Italy) 3.287
Broad-range potential of Asphodelus microcarpus leaves extract for drug development 3.247
Design and synthesis of new isatin derivatives as HIV-1 reverse transcriptase associated ribonuclease H inhibitors 3.192
Molecular Aspects of the RT/drug Interactions. Perspective of Dual Inhibitors 3.191
Multi-target activity of Hemidesmus indicus decoction against innovative HIV-1 drug targets and characterization of Lupeol mode of action 3.186
Studies on Cycloheptathiophene-3-carboxamide Derivatives as Allosteric HIV-1 Ribonuclease H Inhibitors 3.164
Insights into the homo-oligomerization properties of N-terminal coiled-coil domain of Ebola virus VP35 protein 3.126
Biochemical characterization of a multi-drug resistant HIV-1 subtype AG reverse transcriptase: antagonism of AZT discrimination and excision pathways and sensitivity to RNase H inhibitors 2.993
Novel natural non-nucleoside inhibitors of HIV-1 reverse transcriptase identified by shape- and structure-based virtual screening techniques 2.956
Inhibition of HIV-1 reverse transcriptase dimerization by small molecules 2.953
Prenylated phloroglucinols from Hypericum scruglii, an endemic species of Sardinia (Italy), as new dual HIV-1 inhibitors effective on HIV-1 replication 2.919
Design, Synthesis and Biological Evaluation of New 1,3-Diarylpropenones as Dual Inhibitors of HIV-1 RT. 2.919
Relevance of Ebola virus VP35 homo-dimerization on the type I interferon cascade inhibition 2.869
Purification and characterization of DR_2577 (SlpA) a major S-layer protein from Deinococcus radiodurans 2.855
Insights into Ebola Virus VP35 and VP24 Interferon inhibitory functions and their initial exploitation as drug targets 2.851
Onopordum illyricum L., a Mediterranean plant, as a source of anti HIV-1 compounds 2.846
Preliminary study of endemic plants of Sardinia as a source of new antiviral agents 2.807
Site directed mutagenesis studies on HIV-1 reverse transcriptase (RT) shed light on the mechanism of action of a new Ribonuclease H/ DNA polymerase RT dual inhibitor 2.804
Structure-guided approach identifies a novel class of HIV-1 Ribonuclease H inhibitors: Binding mode insights through magnesium complexation and site-directed mutagenesis studies 2.799
Design, Synthesis and Biological Evaluation of New 1,3-Diarylpropenones as Single Site Dual Inhibitors of HIV-1 RT 2.778
Chelation motifs affecting metal-dependent viral enzymes: N′-acylhydrazone ligands as dual target inhibitors of HIV-1 Integrase and Reverse Transcriptase Ribonuclease H domain 2.760
From the traditional Chinese medicine plant Schisandra chinensis new scaffolds effective on HIV-1 reverse transcriptase resistant to non-nucleoside inhibitors 2.758
Hypericum hircinum L. components as new single-molecule inhibitors of both HIV-1 reverse transcriptase-associated DNA polymerase and ribonuclease H activities 2.756
From cycloheptathiophene-3-carboxamide to oxazinone-based derivatives as allosteric HIV-1 ribonuclease H inhibitors 2.740
The S-layer protein DR_2577 binds deinoxanthin and under desiccation conditions protects against UV-radiation in Deinococcus radiodurans 2.739
null 2.719
On the S-layer of Thermus thermophilus and the assembling of its main protein SIpA 2.712
Natural Product Kuwanon-L Inhibits HIV-1 Replication through Multiple Target Binding 2.695
Insights into Ebola VP35 oligomerization from molecular simulations 2.660
Mutagenic study on HIV-1 reverse transcriptase to explore the mechanism of action of HIV-1 reverse transcriptase dual inhibitors 2.656
Development and validation of a novel dual luciferase reporter gene assay to quantify Ebola virus VP24 inhibition of IFN signaling 2.633
Intracellular human antibody fragments recognizing the VP35 protein of Zaire Ebola filovirus inhibit the protein activity 2.622
Chromenone derivatives as a versatile scaffold with dual mode of inhibition of HIV-1 reverse transcriptase-associated Ribonuclease H function and integrase activity 2.605
ANALYSIS OF 98 HERV-K(HML-2) CONTAINING PROVIRUSES IDENTIFIED IN THE HUMAN GENOME ASSEMBLY GRCH37/HG19 BY RETROTECTOR AND THEIR GENOMIC CONTEXT 2.587
New insights into the interaction between pyrrolyl diketoacids and HIV-1 integrase active site and comparison with RNase H 2.585
Active site and allosteric inhibitors of the ribonuclease H activity of HIV reverse transcriptase 2.520
Synthesis and biological activity evaluation of new dual-inhibitors of both associated functions of HIV-1 RT 2.516
Towards the total block of HIV-1 Reverse Transcriptase: the dual-inhibitors approach 2.515
3-[2-(4-aryl-1,3-thiazol-2-yl)hydrazin-1-ylidene]-1H-indol-2-ones as new potential dual inhibitors of polimerase and ribonuclease HIV-1 RT associated function 2.512
Identification of a novel HERV-K(HML10): comprehensive characterization and comparative analysis in non-human primates provide insights about HML10 proviruses structure and diffusion 2.444
Investigation on the mechanism of action of new dual inhibitors of HIV-1 RT 2.426
Use of a Dual Luciferase Cell-Based Drug Screening Assay to Study VP24 Inhibition of JAK/STAT Pathway and its Reversion by Compounds 2.399
Classification and characterization of human endogenous retroviruses; mosaic forms are common 2.381
Human Endogenous Retrovirus type W distribution in the human genome: identification and characterization of a new set of proviral sequences in GRCh37/hg19 assembly 2.342
Contribution of type W human endogenous retroviruses to the human genome: Characterization of HERV-W proviral insertions and processed pseudogenes 2.338
New dual inhibitors of RT associated functions: investigation on their mechanism and mode of action 2.337
Chalcones as novel dual inhibitors of HIV-1 reverse transcriptase 2.336
Meeting report: Fourth Summer School on Innovative Approaches for Identification of Antiviral Agents (IAAASS) 2.335
null 2.329
Integration of SARS-CoV-2 RNA in infected human cells by retrotransposons: an unlikely hypothesis and old viral relationships 2.302
Inhibition of HIV-1 reverse transcriptase associated activities by the hydroalcoholic extract of Casimiroa edulis seeds 2.287
Structure-Activity Relationship of Pyrrolyl Diketo Acid Derivatives as Dual Inhibitors of HIV-1 Integrase and Reverse Transcriptase Ribonuclease H Domain 2.277
An efficient route to novel uracil-based drug-like molecules 2.274
Validation of a computed radiography device to monitor the HIV-1 RNase H activity 2.264
Improvement of the activity of the anti-HIV-1 integrase aptamer T30175 by introducing a modified thymidine into the loops 2.229
Inhibitory effect of 2,3,5,6-tetrafluoro-4-[4-(Aryl)-1H-1,2,3-triazol-1-yl]benzenesulfonamide derivatives on HIV reverse transcriptase associated rnase H activities 2.223
A Luciferase Reporter Gene Assay to Measure Ebola Virus Viral Protein 35–Associated Inhibition of Double-Stranded RNA–Stimulated, Retinoic Acid–Inducible Gene 1–Mediated Induction of Interferon β 2.200
Identification and genomic characterization of HERV-K (HML-10) in human genome GRCh37/hg19 assembly 2.195
Exploring new scaffolds for the inibition of the Ribonuclease H function of RT HIV-1 2.149
1,2,4-Triazolo[1,5-a]pyrimidines as a Novel Class of Inhibitors of the HIV-1 Reverse Transcriptase-Associated Ribonuclease H Activity 2.129
2-(Arylamino)-6-(trifluoromethyl)nicotinic Acid Derivatives: New HIV-1 RT Dual Inhibitors Active on Viral Replication 2.109
Investigation on the sucrose binding pocket of HIV-1 Integrase by molecular dynamics and synergy experiments 2.099
HERV-W group evolutionary history in non-human primates: Characterization of ERV-W orthologs in Catarrhini and related ERV groups in Platyrrhini 2.097
Development and identification of a novel anti-HIV-1 peptide derived by modification of the N-terminal domain of HIV-1 integrase 2.095
Design and synthesis of new Isatin derivatives as HIV-1 Reverse Transcriptase associated Ribonuclease H inhibitors twenty-fourth 2.055
Meeting report: Third Summer School on innovative approaches for identification of antiviral agents (IAAASS) 2.029
Isatin derivatives as new scaffolds for HIV-1 reverse transcriptase associated RNase H and RDDP dual inhibitors 2.020
Discovery of dihydroxyindole-2-carboxylic acid derivatives as dual allosteric HIV-1 Integrase and Reverse Transcriptase associated Ribonuclease H inhibitors 2.000
Design, synthesis and biolgical activity evaluation of new HIV-1 reverse transcriptase dual inhibitors 1.974
Ribonuclease H, an unexploited target for antiviral intervention against HIV and hepatitis B virus 1.971
Alizarine derivatives as new dual inhibitors of the HIV-1 reverse transcriptase-associated DNA polymerase and RNase H activities effective also on the RNase H activity of non-nucleoside resistant reverse transcriptases 1.961
Targeting HIV-1 RNase H: N'-(2-Hydroxy-benzylidene)-3,4,5-Trihydroxybenzoylhydrazone as Selective Inhibitor Active against NNRTIs-Resistant Variants 1.956
New features of the cell wall of the radio-resistant bacterium Deinococcus radiodurans 1.949
Kuwanon-L as a new allosteric HIV-1 integrase inhibitor: molecular modeling and biological evaluation 1.949
Human endogenous retroviruses are ancient acquired elements still shaping innate immune responses 1.948
Ebola virus VP35 blocks stress granule assembly 1.943
Identification of HIV-1 reverse transcriptase dual inhibitors by a combined shape-, 2D-fingerprint- and pharmacophore-based virtual screening approach 1.938
HERV envelope proteins: Physiological role and pathogenic potential in cancer and autoimmunity 1.906
6-(1-Benzyl-1H-pyrrol-2-yl)-2,4-dioxo-5-hexenoic acids as dual inhibitors of recombinant HIV-1 integrase and ribonuclease H, synthesized by a parallel synthesis approach 1.894
Type W Human Endogenous Retrovirus (HERV-W) Integrations and Their Mobilization by L1 Machinery: Contribution to the Human Transcriptome and Impact on the Host Physiopathology 1.885
Design, synthesis and biological activity evaluation of new HIV-1 reverse transcriptase dual inhibitors 1.864
null 1.851
Identification of HIV-1 reverse trascriptase dual inhibitors by a combined shape-, 2D fingerprint and pharmacophore-based virtual screening approch 1.847
Comprehensive Characterization of the Human Endogenous Retrovirus HERV-K(HML-6) Group: Overview of Structure, Phylogeny, and Contribution to the Human Genome 1.828
Design of new inhibitors of the HIV-1 Reverse Transcriptase associated Ribonuclease H function: a synthetic approach 1.779
Antiretroviral activity of metal-chelating HIV-1 integrase inhibitors 1.762
Totale 289.917
Salva come PNG Salva come JPEG
Categoria #
all - tutte 484.735
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 484.735
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202054.054 0 0 0 0 20.904 15.963 8.508 1.648 1.135 1.810 1.351 2.735
2020/202189.881 2.726 3.102 4.132 23.909 16.751 9.705 6.662 5.980 2.364 5.624 6.403 2.523
2021/202223.462 2.379 1.875 1.195 1.419 1.852 1.786 1.324 1.202 2.274 2.345 2.865 2.946
2022/202340.300 3.440 5.633 4.589 3.519 2.514 4.377 1.973 3.178 2.117 2.391 3.242 3.327
2023/202438.637 2.373 1.373 2.010 3.476 3.722 6.385 5.038 3.012 1.887 2.286 3.411 3.664
2024/202577.723 15.305 41.501 10.614 7.743 2.560 0 0 0 0 0 0 0
Totale 415.076